Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

FYVE, RhoGEF and PH Domain Containing 3 (FGD3) (Middle Region) Peptide

FGD3 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN976824

Quick Overview for FYVE, RhoGEF and PH Domain Containing 3 (FGD3) (Middle Region) Peptide (ABIN976824)

Target

FGD3 (FYVE, RhoGEF and PH Domain Containing 3 (FGD3))

Origin

Human

Source

  • 1
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Sequence

    STSPVEPVVT TEGSSGAAGL EPRKLSSKTR RDKEKQSCKS CGETFNSITK

    Characteristics

    This is a synthetic peptide designed for use in combination with anti-FGD3 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    FGD3 (FYVE, RhoGEF and PH Domain Containing 3 (FGD3))

    Background

    FGD3 promotes the formation of filopodia. It may activate CDC42, a member of the Ras-like family of Rho- and Rac proteins, by exchanging bound GDP for free GTP. FGD3 plays a role in regulating the actin cytoskeleton and cell shape.

    Alias Symbols: FLJ00004, MGC117260, ZFYVE5

    Protein Size: 634

    Molecular Weight

    70 kDa

    Gene ID

    89846

    NCBI Accession

    NM_033086, NP_149077
You are here:
Chat with us!